Breakdown | |||||
TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
114.46B | 115.11B | 113.51B | 107.85B | 98.15B | 218.35B | Gross Profit |
56.92B | 53.30B | 55.63B | 53.44B | 48.29B | 49.45B | EBIT |
4.32B | 4.46B | 3.90B | 1.57B | -1.40B | -2.02B | EBITDA |
8.73B | 10.17B | 9.63B | 7.51B | 5.26B | 3.02B | Net Income Common Stockholders |
2.96B | 3.48B | 2.78B | 1.89B | -775.00M | -4.95B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
3.69B | 2.59B | 3.73B | 3.24B | 4.10B | 5.62B | Total Assets |
119.93B | 114.39B | 115.36B | 118.34B | 119.38B | 123.42B | Total Debt |
4.51B | 4.62B | 6.04B | 12.58B | 16.84B | 17.22B | Net Debt |
824.00M | 2.04B | 2.31B | 9.34B | 12.74B | 11.60B | Total Liabilities |
83.81B | 75.81B | 78.05B | 83.76B | 86.07B | 89.78B | Stockholders Equity |
36.11B | 38.58B | 37.32B | 34.59B | 33.31B | 33.64B |
Cash Flow | Free Cash Flow | ||||
0.00 | 2.79B | 6.59B | 4.67B | -1.12B | 146.00M | Operating Cash Flow |
0.00 | 6.73B | 10.17B | 7.56B | 2.50B | 4.30B | Investing Cash Flow |
0.00 | -3.90B | -2.19B | -3.02B | -3.30B | -3.61B | Financing Cash Flow |
0.00 | -3.97B | -7.49B | -5.40B | -715.00M | 1.48B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
76 Outperform | $523.47B | 12.47 | 10.29% | 2.20% | 8.57% | 40.46% | |
74 Outperform | $335.30B | 8.60 | 8.38% | 2.36% | 6.94% | 26.27% | |
73 Outperform | $837.28B | 16.03 | 8.71% | 0.01% | 3.56% | -2.39% | |
70 Neutral | ¥236.16B | 6.53 | 11.92% | 2.07% | 3.71% | 62.31% | |
68 Neutral | ¥56.25B | 22.78 | 1.76% | 16.65% | -9.43% | ||
62 Neutral | $6.82B | 11.05 | 2.80% | 4.32% | 2.67% | -24.92% | |
55 Neutral | ¥71.18B | 20.15 | 1.13% | 1.41% | 27.48% |